FDA punts on ADT … for now
The FDA still doesn’t have draft guidance for manufacturers, importers, and distributors of animal-derived thyroid products.
Being an exceptional compounding professional means you never stop learning
We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
The FDA still doesn’t have draft guidance for manufacturers, importers, and distributors of animal-derived thyroid products.
If your legislator is on one of the congressional committees that have the greatest influence on compounding legislation, we need you at CCH.
We're giving a thumbs-up to a bill that’s actively advancing in the state.
It’s right at the center of some of the biggest issues facing pharmacy compounding.
Congrats to the 2026 recipients of the Pharmacy Compounding Foundation’s technician grants to attend this year’s EduCon.